Alcresta Therapeutics Announces Preclinical Data Evaluating RELiZORBneo Cartridge Use in Neonatal Murine Model of Necrotizing Enterocolitis
PRNewsWire
·
2026-05-01
·
via The Tech Buzz - Press Releases
Preclinical data published in PLOS ONE highlight potential safety benefit of RELiZORBneo WALTHAM, Mass., May 1, 2026 /PRNewswire/ -- Alcresta Therapeutics, Inc., a leading commercial-stage company foc
此内容由惯性聚合(RSS阅读器)自动聚合整理,仅供阅读参考。 原文来自 — 版权归原作者所有。